ABHD14A
Protein ABHD14A
Also known as: ABHEA_HUMAN, DKFZP564O243, DORZ1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BUJ0
- Gene
- ABHD14A
- Ensembl
- ENSG00000248487
- Chromosome
- 3
- Canonical length
- 271 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
Predicted to enable hydrolase activity. Predicted to be located in membrane. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
271 residues, UniProt reviewed canonical sequence.
>Q9BUJ0|ABHD14A
1 MVGALCGCWF RLGGARPLIP LGPTVVQTSM SRSQVALLGL SLLLMLLLYV GLPGPPEQTS
61 CLWGDPNVTV LAGLTPGNSP IFYREVLPLN QAHRVEVVLL HGKAFNSHTW EQLGTLQLLS
121 QRGYRAVALD LPGFGNSAPS KEASTEAGRA ALLERALRDL EVQNAVLVSP SLSGHYALPF
181 LMRGHHQLHG FVPIAPTSTQ NYTQEQFWAV KTPTLILYGE LDHILARESL RQLRHLPNHS
241 VVKLRNAGHA CYLHKPQDFH LVLLAFLDHL PLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ABHD14A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 100 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 100 nTPM
- cerebellum: 92 nTPM
- cerebral cortex: 71 nTPM
- hypothalamus: 65 nTPM
- amygdala: 54 nTPM
- basal ganglia: 54 nTPM
Single-cell type
- cardiomyocytes: 579 nCPM
- other brain neurons: 61 nCPM
- adipocytes: 55 nCPM
- brain excitatory neurons: 46 nCPM
- rod photoreceptor cells: 42 nCPM
- brain inhibitory neurons: 40 nCPM
Immune cell
- MAIT T-cell: 96 nTPM
- gdT-cell: 94 nTPM
- T-reg: 88 nTPM
- memory CD8 T-cell: 83 nTPM
- memory CD4 T-cell: 81 nTPM
- naive CD8 T-cell: 79 nTPM
Brain region
- cerebellum: 75 nTPM
- hypothalamus: 69 nTPM
- choroid plexus: 66 nTPM
- cerebral cortex: 65 nTPM
- basal ganglia: 59 nTPM
- hippocampal formation: 52 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.4
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.33
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ABHD14A as an antibody target. Whether an autoantibody or antibody against ABHD14A could matter depends on whether native ABHD14A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ABHD14A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ABHD14A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...